Economic evaluation in cardiac electrophysiology: Determining the value of emerging technologies

Frontiers in Cardiovascular Medicine

Cardiovascular Medicine

Bert Vandenberk¹  Waseem Hijazi²  Glen Sumner²  Elissa Rennert-May³  Derek S. Chew³  Amity Quinn⁴ 

[1] Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium;Libin Cardiovascular Institute, Department of Cardiac Sciences, University of Calgary, Calgary, AB, Canada;Libin Cardiovascular Institute, Department of Cardiac Sciences, University of Calgary, Calgary, AB, Canada;O’Brien Institute for Public Health, University of Calgary, Calgary, AB, Canada;Department of Medicine, University of Calgary, Calgary, AB, Canada;O’Brien Institute for Public Health, University of Calgary, Calgary, AB, Canada;Department of Medicine, University of Calgary, Calgary, AB, Canada;

关键词: cost effectiveness analysis (CEA);    economic evaluation (cost effectiveness);    cardiac electrophysiogy;    atrial fibrilation (AF);    ICD (implantable cardioverter-defibrillator);    CRT-D;    cardiac resynchronization therapy–defibrillator;    anticoagulation (AC);    ablation < electrophysiology;   

DOI  :  10.3389/fcvm.2023.1142429

 received in 2023-01-11, accepted in 2023-04-03,  发布年份 2023

来源: Frontiers

【 摘 要 】

Cardiac electrophysiology is a constantly evolving speciality that has benefited from technological innovation and refinements over the past several decades. Despite the potential of these technologies to reshape patient care, their upfront costs pose a challenge to health policymakers who are responsible for the assessment of the novel technology in the context of increasingly limited resources. In this context, it is critical for new therapies or technologies to demonstrate that the measured improvement in patients' outcomes for the cost of achieving that improvement is within conventional benchmarks for acceptable health care value. The field of Health Economics, specifically economic evaluation methods, facilitates this assessment of value in health care. In this review, we provide an overview of the basic principles of economic evaluation and provide historical applications within the field of cardiac electrophysiology. Specifically, the cost-effectiveness of catheter ablation for both atrial fibrillation (AF) and ventricular tachycardia, novel oral anticoagulants for stroke prevention in AF, left atrial appendage occlusion devices, implantable cardioverter defibrillators, and cardiac resynchronization therapy will be reviewed.

【 授权许可】

Unknown   
© 2023 Hijazi, Vandenberk, Rennert-May, Quinn, Sumner and Chew.